| Document |
Document Title |
|
WO/2007/069684A1 |
Disclosed is a phthalamide derivative represented by the general formula (I) or a salt thereof, which shows an excellent controlling effect for use as an agricultural or horticultural pesticide alone or in combination with other agricult...
|
|
WO/2007/068894A2 |
The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory- disorders, pharmaceutical compositions containing them, and processes for their preparation.
|
|
WO/2007/069271A2 |
The present invention relates to process for purification of (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-t
etrazol-5-yl)biphenyl-4-ylmethyl]-amine.
|
|
WO/2007/064227A1 |
The present invention relates to novel compounds of formula (I) and (II), compositions comprising compounds of formula (II) and their use as contrast agents in magnetic resonance (MR) imaging (MRI) and MR spectroscopy (MRS).
|
|
WO/2007/063789A1 |
Disclosed are a compound having a strong COMT inhibitory effect and represented by the general formula (I) below, a pharmacologically acceptable salt thereof, a pharmaceutical composition containing either of them, and uses of them. (I) ...
|
|
WO/2007/060026A1 |
The present invention provides compounds of formula (I): in which Y is oxygen or sulphur; R1 and R”1 are optionally substituted aryl, heteroaryl or a fused ring structure, R2 and R'2 are each H, or optionally substituted alkyl, alkylam...
|
|
WO/2007/059908A1 |
The invention relates to antibacterial cyclic iminopeptide derivatives and to a process for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for producing medicaments for the treatment and...
|
|
WO/2007/057919A2 |
An improved process for prepariang Valsartan of formula (I), by carrying out hydrolysis of Valsartan ester derivative of formula (II) in presence of phase transfer catalyst.
|
|
WO/2007/054965A2 |
The present invention relates to process for preparation of tetrazoles of formula (I) from aromatic cyano derivatives of formula (II) comprising of treating the cyano compound of formula (II) with trialkyltin halide and metal azide in pr...
|
|
WO/2007/048771A1 |
A compound of formula (I), wherein substituents are as given above, useful in the treatment of a disease mediated by the action of CCR3, in particular inflammatory or obstructive airway diseases.
|
|
WO/2007/045369A1 |
The present application relates to new difluorophenol derivatives, methods for preparing the same, their use for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of ...
|
|
WO/2007/045675A1 |
The invention provides a method for obtaining the intermediate (II), useful for manufacturing Valsartan and a drug directed to a treatment of arterial hypertension or heart failure. The process comprises a) Imination of the aldehyde grou...
|
|
WO/2007/045370A1 |
The present application relates to new tetrazol derivatives, methods for preparing the same, their use for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of diseas...
|
|
WO/2007/047447A2 |
The present invention provides compounds that are effective in treating central nervous system disorders and maintaining normal brain function. Methods of making and using the compounds are also provided.
|
|
WO/2007/044724A2 |
Compounds of formula (I), useful for inhibiting PIM-I and/or PIM-3: and pharmaceutically acceptable salts thereof, wherein Y, Z, R1, R3, Q, X and R4 are as defined above. Pharmaceutical compositions and methods of treating diseases and c...
|
|
WO/2007/042506A1 |
The present invention relates to a compound of formula (II) chosen from (IIa) and (IIb) or of formula (VI) chosen from (VIa) and (VIb) of following general formulae: in which: X1, X2, X3, X4 and X5 represent, independently of one another...
|
|
WO/2007/037685A1 |
The invention relates to the field of antibiotic compositions, both inside and outside the medical field. Presented is a new class of antibiotic compounds, the bis(1-aryl-5-tetrazolyl)methanes, which are especially useful for combating i...
|
|
WO/2007/035964A2 |
Compounds bioisoteric to vigabatrin and related methods of use.
|
|
WO/2007/033002A1 |
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: (F) where the definitions of the variables Q, L1, , L2, M, X, L3, and A are provided ...
|
|
WO/2007/029021A1 |
The present invention pertains to certain 1,5-substituted-1H-tetrazole compounds that, inter alia, inhibit 11β- hydroxysteroid dehydrogenase type 1 (11β-HSD1). The present invention also pertains to pharmaceutical compositions comprisi...
|
|
WO2006050444A9 |
A poly(tetrazole) is formed by a water-based method. A gas generating composition (12) containing the poly(tetrazole) is contained within an exemplary gas generator (10). A gas generating system (200) incorporates the poly(tetrazole) the...
|
|
WO/2007/029587A1 |
Disclosed is a compound represented by the formula (1) below which is useful as a drug for treating Alzheimer's disease, or a pharmaceutically acceptable salt thereof. (1) [In the formula, R1 represents a group represented by the followi...
|
|
WO/2007/029036A2 |
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...
|
|
WO/2007/025586A1 |
Disclosed are compounds of formula (I), wherein R1 represents cycloalkyl, and the stereoisomers and any mixtures thereof. Said compounds are excellent microbicides used for protecting plants and materials.
|
|
WO/2007/026962A1 |
It is intended to provide a novel phenylene derivative represented by the following general formula (I), which is useful as a remedy or a preventive for renal disorders (nephritis, nephropathy, nephrosclerosis, renal failure and so on), ...
|
|
WO2006138510B1 |
The present invention is related substituted enaminones represented by a compound of Formula I that are novel allosteric modulators of a7 nAChRs. The invention also discloses the treatment of disorders that are responsive to enhancement ...
|
|
WO/2007/023915A1 |
Disclosed is an imprint polymer having a recognition site which is reversibly bound to a target protein. Since the recognition site has at least one of a metal complex and a substrate inhibitor, the imprint polymer can have a high specif...
|
|
WO/2007/017897A2 |
Disclosed herein is novel crystalline forms of Valsartan namely, a crystalline form designated as Form A, and its solvates thereof, novel crystalline form of Valsartan designated as Form B and solvates thereof, novel crystalline form of ...
|
|
WO/2007/017267A2 |
Compounds of formula (I): are inhibitors of bacterial phenylalanyl t-RNA synthetase and are of use in treating bacterial infections.
|
|
WO/2007/014412A1 |
The invention relates to a method for isolating 5-substituted tetrazoles of general formula (I) in which R represents a substituted biphenyl radical during which the ring closure, starting from a corresponding nitrile, is carried out in ...
|
|
WO/2007/009637A2 |
The invention relates to the objects which are characterised in the patent claims, that is, metal complexes which contain perfluoroalkyl having N-alkyl groups of general formula (I), to a method for the production thereof and to the use ...
|
|
WO/2007/010653A1 |
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...
|
|
WO/2007/009638A2 |
The invention relates to objects which are characterised in the claims, that is, metal complexes containing perfluoroalky, comprising radicals of general formula I containing nitrogen, to a method for the production and use thereof in th...
|
|
WO/2007/006531A1 |
The invention relates to a method or process for the manufacture of blood pressure lowering agents, such as valsartan, novel intermediates as well as process steps in said synthesis. The method or process leads via the novel intermediate...
|
|
WO/2007/005845A1 |
The invention provides novel compounds of formulae I and II: Formulae (I) and (II) that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipid...
|
|
WO/2007/005967A2 |
Provided is a process for preparing valsartan and precursors thereof.
|
|
WO/2007/002557A1 |
The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and meth...
|
|
WO/2007/001406A2 |
The present invention discloses novel compounds, compositions containing the compounds and methods for the treatment of viral infection, particularly hepatitis C and SARS. In particular the invention provides aryl-containing macrocyclic ...
|
|
WO/2006/133216A2 |
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.
|
|
WO/2006/131228A1 |
Disclosed is a method for producing substituted azoles. Said method makes it possible to produce compounds of general formula (I) and/or the salts thereof and/or the acid addition compounds thereof, wherein the substituents R1 and R2, A,...
|
|
WO/2006/132811A2 |
The present invention relates to AMPA receptor potentiators of Formula (I), formulations comprising them, methods for their use, and intermediates useful for their preparation.
|
|
WO/2006/130403A1 |
Certain novel phenylalkyl substituted azole derivatives have unexpected insecticidal activity. These compounds are represented by formula I: where A, B, D, E, G, a, b, c, d, and R through R11, inclusively, are folly described herein. In ...
|
|
WO/2006/127871A2 |
The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.
|
|
WO/2006/127503A2 |
The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally subs...
|
|
WO/2006/120574A2 |
The invention relates to analogs of 4-hydroxyisoleucine, and to lactones, pharmaceutically acceptable salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. The analogs of...
|
|
WO/2006/120444A1 |
The invention provides a compound comprising a xanthone or thiaxanthone sensitising moiety, capable of coordinating to a lanthanide ion by the nitrogen atom of an integral pyridyl group or a related group able to bind a lanthanide ion.
|
|
WO/2006/115834A1 |
The compounds of the present invention are polymorphic crystalline forms of the compound 2-butyl-4-chloro-1-[(2’-(1-H-tetrazol-5-yl)biphenyl-4-yl)m
ethyl]-imidazole-5-carboxylic acid, which has the structure (I). Specifically, the comp...
|
|
WO/2006/114575A1 |
The invention provides a photographic element comprising a support bearing at least one silver halide emulsion layer and associated therewith (a) at least one coupler capable of releasing a development accelerator on colour development (...
|
|
WO/2006/113150A1 |
The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.
|
|
WO/2006/112685A1 |
Azole compounds containing carbamoyl group and pharmaceutically useful salts thereof are described. The compounds are effective anticonvulsants which are used in the treatment of disorders of the central nervous system, especially as anx...
|
